Rosetta Genomics Ltd (ROSG.OQ)

ROSG.OQ on NASDAQ Stock Exchange Capital Market

24 Dec 2014
Price Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for ROSG.OQ


Rosetta Genomics Ltd. is seeking to develop and commercialize new diagnostic products based on a discovered group of genes known as microRNAs. The Company has established a clinical laboratory improvement amendment (CLIA)-certified laboratory in Philadelphia, which enables it to commercialize its own diagnostic tests applying... (more)


Beta: -2.97
Market Cap (Mil.): $27.53
Shares Outstanding (Mil.): 11.72
Dividend: --
Yield (%): --


  ROSG.OQ Industry Sector
P/E (TTM): -- 151.49 38.63
EPS (TTM): -1.00 -- --
ROI: -56.96 -0.58 18.27
ROE: -57.67 -1.67 19.14
Search Stocks

European probe lands on comet, but fails to anchor down

BERLIN/FRANKFURT - The European Space Agency landed a probe on a comet on Wednesday, a first in space exploration and the climax of a 10-year-odyssey, but an anchoring system problem may hamper planned investigations into the origins of Earth and the solar system. | Video

12 Nov 2014

UPDATE 3-Europe makes space history as Philae probe lands on comet

* Anchors did not deploy as planned (Adds reaction, comment on Philae anchors)

12 Nov 2014

Rosetta lander starts descent to comet in historic space mission

BERLIN/FRANKFURT - European scientists launched a probe from spaceship Rosetta on Wednesday in an historic attempt to examine the surface of a comet, starting a seven-hour descent that is seen as the most difficult phase of a ten-year mission.

12 Nov 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.
Provider: Pechala's Reports
Provider: Pechala's Reports
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks